This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
BIO-Europe 2020

Biopharma Partnering and Financing Trends, H1 2020

Posted by on 01 October 2020
Share this article

For the fifth year, Pharma Intelligence has analyzed the types of alliances, the scope of dealmaking activity, and the myriad of opportunities that continue to drive drug development in the biopharma industry. In their new white paper, Biopharma Partnering and Financing Trends, H1 2020, we learn the impact COVID-19 has had on the industry and how the first half of 2020 compares with the first half of 2019.

Just cover of Partnering Trends report


Read about:

Deal volume

Financial value of the deals made

Reasons why deal volumes changed from one quarter to another

Highest partnership therapy areas

Impact COVID-10 had on partnership activity

The effect announced milestones had on deals

Share this article

Sign up for Partnering, Business Development & Licensing email updates